Floch Martin H, Madsen Karen K, Jenkins David J A, Guandalini Stefano, Katz Jeffery A, Onderdonk Andrew, Walker W Allan, Fedorak Richard N, Camilleri Michael
Yale University School of Medicine, New Haven, CT 06520-8019, USA.
J Clin Gastroenterol. 2006 Mar;40(3):275-8. doi: 10.1097/00004836-200603000-00022.
Probiotics are live microbial organisms that are administrated as supplements or in foods to benefit the host. It is the recommendation that they may be helpful in the prevention and treatment of acute diarrhea in adults and children, the prevention of antibiotic-associated diarrhea in adults and children, and the maintenance of remission and prevention of pouchitis. Although early results indicate that probiotics may also be useful in immunologic modulation to prevent atopy, treatment of radiation intestinal disease, vaginosis, ulcerative colitis, and the irritable bowel syndrome, the studies available are not sufficient to say they are definitely helpful. Even fewer data are available to recommend probiotics for the treatment of H pylori and Crohn disease and for the prevention of cardiovascular risk factors or other degenerative diseases. Clearly, larger and better-designed studies of probiotics are necessary, including comparative and dose-ranging trials.
益生菌是作为补充剂或添加于食品中服用的活微生物,对宿主有益。建议益生菌有助于预防和治疗成人及儿童的急性腹泻、预防成人及儿童抗生素相关性腹泻、维持缓解状态及预防袋炎。尽管早期结果表明益生菌在免疫调节以预防特应性疾病、治疗放射性肠道疾病、阴道炎、溃疡性结肠炎和肠易激综合征方面可能也有用,但现有研究不足以确定其肯定有益。关于推荐益生菌用于治疗幽门螺杆菌和克罗恩病以及预防心血管危险因素或其他退行性疾病的数据更少。显然,需要开展更大规模、设计更优的益生菌研究,包括对比试验和剂量范围试验。